Semaglutide - 1mg Liquid Injection For Type 2 Diabetes Management | Weekly Dosage, Suitable For Adults, Prescribed For Weight Management

Semaglutide is a treatment for type 2 diabetes which has recently been licensed to be used for weight management under the brand name Wegovy.
When it is readily available in the UK, it will be able to be prescribed to adults with a BMI of more than 30 (or over 27 if weight-related health conditions are present) who have struggled to lose weight through natural methods such as diet, exercise and other lifestyle changes.
Ita s taken as a weekly injection and studies have shown that it has the potential to be a very effective treatment in those who need it.

What is Semaglutide?
Semaglutide is a medicine that was first developed to treat type 2 diabetes in adults, as it helps to reduce blood glucose levels which can often be quite high in people with diabetes.